Valeurs | |||||
Le rangement donne un aperçu de toutes les valeurs mobilières classées de manière alphabétique ou selon les indices. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Nom | Code | Analysis date | Cours de clôture | +/- % |
Axon Enterprise | AXON | 8. jan 2025 | 577.34 | +2.72 |
Baker Hughes A | BKR | 8. jan 2025 | 43.44 | +0.09 |
Ball | BALL | 8. jan 2025 | 53.46 | -0.43 |
Bank Of America | BAC | 8. jan 2025 | 46.21 | +0.28 |
Bank Of New York Mellon | BK | 8. jan 2025 | 77.95 | -0.01 |
Baxter International | BAX | 8. jan 2025 | 29.59 | +0.03 |
Becton, Dickinson And Co | BDX | 8. jan 2025 | 234.43 | +0.98 |
Berkshire Hathaway B | BRK-B | 8. jan 2025 | 451.84 | -0.24 |
Best Buy | BBY | 8. jan 2025 | 84.19 | -0.11 |
Bio-Techne | TECH | 8. jan 2025 | 75.19 | +0.56 |
Biogen | BIIB | 8. jan 2025 | 150.75 | -1.57 |
BlackRock | BLK | 8. jan 2025 | 986.10 | +0.54 |
Blackstone | BX | 8. jan 2025 | 173.97 | +1.54 |
Boeing | BA | 8. jan 2025 | 171.76 | -0.43 |
Booking | BKNG | 8. jan 2025 | 4 872.42 | +1.59 |
BorgWarner | BWA | 8. jan 2025 | 31.54 | -2.26 |
Boston Properties | BXP | 8. jan 2025 | 69.93 | -0.57 |
Boston Scientific | BSX | 8. jan 2025 | 95.95 | +4.30 |
Bristol-Myers Squibb | BMY | 8. jan 2025 | 56.81 | -0.58 |
Broadcom | AVGO | 8. jan 2025 | 229.31 | +0.29 |
Broadridge Financial Solutions | BR | 8. jan 2025 | 229.49 | +1.40 |
Brown & Brown | BRO | 8. jan 2025 | 102.53 | +1.44 |
Brown Forman B | BF-B | 8. jan 2025 | 35.99 | -0.66 |
Builders Firstsource | BLDR | 8. jan 2025 | 143.50 | +0.13 |
Bunge | BG | 8. jan 2025 | 77.38 | -0.55 |
C.H. Robinson Worldwide | CHRW | 8. jan 2025 | 103.61 | -0.42 |
Cadence Design Systems | CDNS | 8. jan 2025 | 302.73 | +0.35 |
Caesars Entertainment | CZR | 8. jan 2025 | 31.98 | -3.24 |
Camden Property Trust | CPT | 8. jan 2025 | 111.04 | +0.66 |
Campbell Soup | CPB | 8. jan 2025 | 39.23 | -1.80 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.